NEW YORK, Jan 22 (Reuters) -
U.S. consumer goods maker Procter & Gamble ( PG ) will again
look to hike prices on its household basics such as Tide
detergent if President Donald Trump imposes new tariffs that
increase the cost of imports, an executive said Wednesday.
"Whatever the administration decides to do, we will be able
to deal with," P&G chief financial officer Andre Schulten said
on a call with reporters following quarterly earnings. He added
the company will first try to offset possible tariffs by cutting
costs.
"And what we can't offset with productivity, it might result
in incremental pricing," Schulten added.
P&G's sales volumes rose in the quarter ended Dec. 31, while
the company kept prices flat across its global portfolio of dish
soaps, laundry detergents and toilet papers.
The company, viewed by investors as a top operator in the
cut-throat consumer products industry, buys inputs like
chemicals, razor blades and small electronics from around the
world and manufactures the final product closer to consumers in
local factories.
P&G has frequently hiked prices over the last several years
as it faced escalating costs on fuel and labor. Trump's proposed
round of new tariffs - which could first target Mexico and
Canada - could further add to those costs.
"I think it's still a risk," said Michael Ashley Schulman,
chief investment officer at P&G investor Running Point Capital.
"It's a little hard to quantify, how much of that tariff they
can pass through to consumers."
Over the last four years the company has overhauled its
razor blade supply chain for its Gillette brand, a move that
could cushion its margins under new tariffs. P&G competitor
Edgewell also told Reuters earlier this year it was looking to
lock in Chinese chemical supply for its sunscreens ahead of
possible tariffs.
Schulten said P&G also had "formulation flexibility,"
meaning it can adjust the ingredients in its products if they
became too expensive or unavailable due to tariffs.
P&G, grappling with a supply chain crisis after the COVID-19
pandemic, invested $6 billion in U.S. manufacturing in the last
six years, Schulten added.